Skip to Content

Personal Genomes

Individual sequencing could be around the corner.
October 1, 2001

The Human Genome Project’s working draft sequence, which was completed to much fanfare in June 2000, took about a dozen years and more than $300 million to complete. The result was a composite map of the DNA from several people-a sort of averaged genetic picture of a human. But a growing number of companies are working on advanced technologies that could make it possible to have your own individual genome sequenced in a day, perhaps for as little as a few thousand dollars.

No one’s genetic makeup matches “the human genome” exactly; the differences are what give one person brown eyes and another blue or make some people more susceptible to heart disease. The new technologies could give anyone access to the unique, letter-by-letter sequence of his or her entire genome and help doctors detect the variations that signal health problems down the road.

Today’s sequencing methods are costly and slow in part because for each DNA letter read-of the roughly three billion in a human genome-researchers need to synthesize a separate copy of the DNA strand. Making the copies requires several chemical reactions; then you have to separate and identify the newly made strands. In contrast, two new techniques being developed could read the sequence directly from one DNA molecule. The first method, called “nanopore sequencing,” involves pushing a strand of DNA through a tiny hole surrounded by sensors that detect the electrical changes caused by each DNA letter. The second takes advantage of an enzyme called DNA polymerase, which copies DNA inside our cells. Researchers use specialized optics to detect each letter added as the enzyme copies the original DNA strand.

In May, Palo Alto, CA-based Agilent Technologies signed an agreement with Harvard researchers Daniel Branton and Jene Golovchenko to further develop nanopore sequencing, which Branton coinvented (see “Hole in the Wall Offers Cheaper Sequencing,” TR May/June 1998). Also this year, Woburn, MA-based U.S. Genomics received its first patents on technologies that combine the two direct techniques. Thanks to these and several other efforts (see table), the dream of sequencing a human genome in just a day could be a reality in two to five years, says George Weinstock, codirector of the Baylor College of Medicine Human Genome Sequencing Center in Houston. “They’re all very clever techniques,” he says. “We’re getting very close to having them in hand.”

Though the new sequencing tools will initially be used for biomedical research, they could eventually find their way into doctors’ offices, not only providing for quick gene-based diagnosis of a host of diseases, but also helping doctors choose medicines tailored to individual patients. The expected price tag to sequence your genome-perhaps $5,000 to $30,000-might seem steep, but “it’s kind of a life investment,” says Harvard Medical School biophysicist George Church. “I would pay $10,000 to get my genome sequencedrather than buying a second car.”

Keep Reading

Most Popular

DeepMind’s cofounder: Generative AI is just a phase. What’s next is interactive AI.

“This is a profound moment in the history of technology,” says Mustafa Suleyman.

What to know about this autumn’s covid vaccines

New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.

Human-plus-AI solutions mitigate security threats

With the right human oversight, emerging technologies like artificial intelligence can help keep business and customer data secure

Next slide, please: A brief history of the corporate presentation

From million-dollar slide shows to Steve Jobs’s introduction of the iPhone, a bit of show business never hurt plain old business.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at with a list of newsletters you’d like to receive.